TY - JOUR
T1 - The efficacy of papaverine administration by different routes for the treatment of experimental acute cerebral vasospasm
AU - Liu, Hon Man
AU - Tu, Yong Kwang
N1 - Funding Information:
This work was supported by research grant NSC-85-2331-B-002-344 from the National Council of Science, ROC (Taiwan). Thanks are due to the technologists of Department of Medical Imaging in National Taiwan University Hospital for their help in collecting data.
PY - 2002/1/1
Y1 - 2002/1/1
N2 - Objective: To compare the effect of papaverine (PPV) by different routes of administration for the treatment of experimental acute cerebral vasospasm. Methods: A rabbit model of acute cerebral vasospasm induced by autologous blood injected into the basilar and prepontine cistern was used. The PPV (2 mg/kg) was injected either by an intravenous (IV), intra-arterial (IA), intra-cisternal (IC), or combination of intra-arterial and intra-cisternal (IA + IC) routes. Basilar artery diameters were measured before and after vasospasm was induced and after PPV treatment. Results: Induction of vasospasm reduced basilar artery: diameters by more than 50% in all animals. Compared to artery diameters before vasospasm, diameters after PPV treatment via the IV route were only reduced by 0.5±4.7%. Other reductions in the diameter included 29.1±10.4%, about 1.8±3.1%, and about 26.7±8.4% in the IA, IC, and IA + IC groups, respectively. However, IA administration of PPV caused obvious side effects. Conclusion: Intra-arterial application of the PPV was the most effective way to treat vasospasm in this study. The efficacy of IC route in our study did not confirm the results of prior study. The possibility of side effects of PPV via the IA route should be considered before clinical application.
AB - Objective: To compare the effect of papaverine (PPV) by different routes of administration for the treatment of experimental acute cerebral vasospasm. Methods: A rabbit model of acute cerebral vasospasm induced by autologous blood injected into the basilar and prepontine cistern was used. The PPV (2 mg/kg) was injected either by an intravenous (IV), intra-arterial (IA), intra-cisternal (IC), or combination of intra-arterial and intra-cisternal (IA + IC) routes. Basilar artery diameters were measured before and after vasospasm was induced and after PPV treatment. Results: Induction of vasospasm reduced basilar artery: diameters by more than 50% in all animals. Compared to artery diameters before vasospasm, diameters after PPV treatment via the IV route were only reduced by 0.5±4.7%. Other reductions in the diameter included 29.1±10.4%, about 1.8±3.1%, and about 26.7±8.4% in the IA, IC, and IA + IC groups, respectively. However, IA administration of PPV caused obvious side effects. Conclusion: Intra-arterial application of the PPV was the most effective way to treat vasospasm in this study. The efficacy of IC route in our study did not confirm the results of prior study. The possibility of side effects of PPV via the IA route should be considered before clinical application.
KW - Cerebral artery
KW - Papaverine
KW - Spasm
KW - Subarachnoid hemorrhage
UR - http://www.scopus.com/inward/record.url?scp=0036744181&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036744181&partnerID=8YFLogxK
U2 - 10.1054/jocn.2001.1036
DO - 10.1054/jocn.2001.1036
M3 - Article
C2 - 12383416
AN - SCOPUS:0036744181
SN - 0967-5868
VL - 9
SP - 561
EP - 565
JO - Journal of Clinical Neuroscience
JF - Journal of Clinical Neuroscience
IS - 5
ER -